N/A Completed N=72 Randomized Triple-blind Treatment

Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke

Hemiparesis · Stroke

Source: ClinicalTrials.gov NCT01662960 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

May 2019

Primary outcomePrimary: Upper Extremity Fugl-Meyer — 43.8; 21.4; 42.8; 21.5 score on a scale — p=.443

Summary

The purpose of the study is to determine whether an existing treatment for problems that participants have with making movements after a stroke can be performed at home.

Outcome Measures

Outcome	Result	p-value
PRIMARY Upper Extremity Fugl-Meyer	43.8; 21.4; 42.8; 21.5	.443
PRIMARY Action Research Arm Test	39.9; 7.1; 39.1; 7.7	.80
PRIMARY Rivermead Assessment of Somatosensory Performance	0.76; 0.52; 0.79; 0.60	.93
PRIMARY Virtual-reality Assessment of Navigation	—	—
SECONDARY Stroke Impact Scale	221.0; 231.6; 237.8; 217.0	.28
SECONDARY Wolf Motor Function Test	50.0; 22.3; 50.4; 24.7	.86

Eligibility Criteria

Inclusion Criteria

6 months or more post-stroke
upper extremity Fugl-Meyer score between 10 and 50
no longer participating in upper-extremity physical or occupational therapy
sufficient comprehension ability to understand instructions

Exclusion Criteria

previous head trauma, psychiatric illness or chronic exposure to medications that might be expected to have lasting consequences for the central nervous system (e.g., haloperidol, dopaminergics)
dementia

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01662960). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.